Abstract
The time course of an observed pharmacological effect is affected not only by the kinetics of the drug levels at the site of action but also by parameters such as the slope and maximum effect of the functional relationship between drug level and response. Using clonidine as a test drug, it was found that the kinetics of its effects on blood pressure and pain responses cannot be described by the time course of clonidine levels in the blood, brain, or the hypothetical tissue compartment of the two-compartment characteristics of this drug. However, the results can be explained assuming that the observed pharmacological effects of a drug are composed of the sum of responses from at least two receptor sites with different slopes and maximal effects. The effect of intravenously administered clonidine on blood pressure in the rat was found to be related to the blood concentrations at least at two receptor sites with opposite effects, one leading to a hypertensive and the other to a hypotensive response. Predictions indicate that a maximum decrease of arterial blood pressure is obtained when the steady-state blood concentration of clonidine is about 1 ng/ml and that no effect is seen at 10 ng/ml. Higher levels will produce an increase of the pressure. The kinetics of the analgesic effect of clonidine in the rat could best be related to the brain levels if the observed effect was considered to be derived from the sum of activity at two receptor sites each producing analgesia. The kinetics of the effects of clonidine on the nictitating membrane of the cat was found to be determined by the kinetics of the drug in the peripheral compartment of the two-compartment open model. Consideration of multiple receptor responses is suggested for future studies on the relationship between the kinetics of drug levels and pharmacological responses.
Similar content being viewed by others
References
M. Gibaldi, G. Levy, and H. Weintraub. Drug distribution and pharmacological effects.Clin. Pharmacol. Ther. 12:734–742 (1971).
J. G. Wagner.Fundamentals of Clinical Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill., 1975, pp. 317–318.
B. Dahlström. Studies of the pharmacokinetics of morphine and codeine with emphasis on its relation to analgesia.Acta Univ. Upsaliens. 28:1–55 (1977).
L. Paalzow and G. Paalzow. Blood and brain concentration of morphine and its relation to the analgesic activity in mice.Acta Pharmacol. Suec. 8:329–336 (1971).
B. Dahlström, L. K. Paalzow, G. Segre, and A. J. Ågren. Relation between morphine pharmacokinetics and analgesia.J. Pharmacokin. Biopharm. 6:41–53 (1978).
L. K. Paalzow and P. O. Edlund. Pharmacokinetics of clonidine in the rat and cat.J. Pharmacokin. Biopharm. 7:481–494 (1979).
J. G. Wagner. Relations between drug concentration and response.J. Mond. Pharm. 4:279–310 (1971).
G. Levy. Kinetics of drug action in man.Acta Pharmacol. Toxicol. 29:203–210 (1970).
G. Levy, M. Gibaldi, and W. J. Jusko. Multicompartment pharmacokinetic models and pharmacological effects.J. Pharm. Sci. 58:422–424 (1969).
J. W. Kebabian. Multiple classes of dopamine receptors in mammalian central nervous system: The involvement of dopamine-sensitive adenylyl cyclase.Life Sci. 23:479–484 (1978).
G. Paalzow and L. Paalzow. Theophylline increased sensitivity to nociceptive stimulation and regional turnover of rat brain 5-HT, noradrenaline and dopamine.Acta Pharmacol. Toxicol. 34:157–173 (1974).
G. Paalzow. The potential role of catecholamines in drug induced changes of central pain responses, with special emphasis on morphine effects in the rat.Acta Univ. Upsaliens. 9:1–45 (1976).
H. Schmitt, H. Schmitt, J. R. Boissier, J. F. Giudicelli, and J. Fichelle. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155).Eur. J. Pharmacol. 2:340–346 (1968).
H. Klupp, F. Knappen, Y. Otsuka, I. Streller, and H. Teichmann. Effects of clonidine on central sympathetic tone.Eur. J. Pharmacol. 10:225–229 (1970).
W. Kobinger. In O. Onesti, K. E. Kim, and I. J. Meyer (eds.),Hypertension Mechanisms and Management, Grune and Stratton, New York, 1973, pp. 369–382.
G. Haeusler. Further similarities between the action of clonidine and a central activation of the depressor baroreceptor reflex.Naunyn-Schmiedeberg's Arch. Pharmacol. 285:1–14 (1974).
H. Schmitt, H. Schmitt, and S. Fenard. Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: Antagonism by piperoxane.Eur. J. Pharmacol. 14:98–100 (1971).
D. S. Davies, L. M. H. Wing, J. L. Reid, D. M. E. Neill, P. Tippet, and C. T. Dollery. Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine.Clin. Pharmacol. Ther. 21:593–601 (1977).
L. Finch. The cardiovascular effects of intraventricular clonidine and Bay 1470 in conscious hypertensive cats.Br. J. Pharmacol. 52:333–338 (1974).
H. Ozawa, C.-S. Chen, H. Watanabe, and T. Uematsu. Effect of clonidine on blood pressure, heart rate and body temperature in conscious rats.Jpn. J. Pharmacol. 27:47–54 (1977).
G. Georgsson Trolin. Involvement of α-adrenergic receptors at different levels of the central nervous system in the regulation of blood pressure and heart frequency.Acta Physiol. Scand. Suppl. 430:1–41 (1975).
S. Christersson, M. Frisk-Holmberg, and L. Paalzow. Steady state plasma concentration of clonidine and its relation to the effects on blood pressure in normotensive and hypertensive rats.J. Pharm. Pharmacol. 31:418–419 (1979).
G. Paalzow and L. Paalzow. Morphine-induced inhibition of different pain responses in relation to the regional turnover of rat brain noradrenaline and dopamine.Psychopharmacologia 45:9–20 (1975).
G. Paalzow and L. Paalzow. Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.Naunyn-Schmiedeberg's Arch. Pharmacol. 292:119–126 (1976).
V. F. Smolen. Bioavailability and pharmacokinetic analysis of drug responding systems.Ann. Rev. Pharmacol. 18:495–523 (1978).
R. L. Galeazzi, L. Z. Benet, and L. B. Sheiner. Relationship between the pharmacokinetics and pharmacodynamics of procainamide.Clin. Pharmacol. Ther. 20:278–289 (1976).
G. Segré. Kinetics of interaction between drugs and biologic systems.Il Farmaco Ed. Sci. 23:907–918 (1968).
L. B. Sheiner, D. R. Stanski, S. Vozeh, R. D. Miller, and J. Ham. Simultaneous modelling of pharmacokinetics and dynamics: Application tod-tubocurarine. Clin. Pharmacol. Ther.25:358–371 (1979).
L. Paalzow. Analgesia produced by clonidine in mice and rats.J. Pharm. Pharmacol. 26:361–363 (1974).
C. M. Metzler, G. L. Elfring, and A. J. McEwen.A User's Manual for NONLIN and Associated programs, Upjohn Co., Kalamazoo, Mich., 1974.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Paalzow, L.K., Edlund, P.O. Multiple receptor responses: A new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug: Studies on clonidine in the rat and cat. Journal of Pharmacokinetics and Biopharmaceutics 7, 495–510 (1979). https://doi.org/10.1007/BF01062391
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062391